Fetal Hemoglobin Glycation May Reflect Hyperglycemia in Utero

This article originally appeared here.
Fetal Hemoglobin Glycation May Reflect Hyperglycemia in Utero
Fetal Hemoglobin Glycation May Reflect Hyperglycemia in Utero

(HealthDay News) — Glycation of the α-chain (Glα) in fetal hemoglobin is higher in neonates from women with gestational diabetes mellitus and may reflect hyperglycemia exposure in utero, according to a study published online July 10 in Diabetes Care.

Felix O. Dupont, from the Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke in Canada, and colleagues conducted a case-control study involving 37 women with gestational diabetes mellitus and 30 pregnant women with normal glucose tolerance. They measured the percentage of glycated hemoglobin in cord blood using a unique mass spectrometry method.

The researchers found that in neonates from women with gestational diabetes mellitus, Glα was higher (2.32 vs. 2.20%; P<0.01). In the overall cohort, and in each group, Glα correlated with maternal hemoglobin A1c measured at delivery (overall cohort: r=0.67; P<0.0001; gestational diabetes mellitus group: r=0.66; P<0.0001: normal glucose tolerance group: r=0.50; P=0.01).

"Thus, Glα may reflect hyperglycemic exposure during the last weeks of fetal development," the authors write. "Future studies will confirm Glα is a predictive biomarker of prenatally programmed lifetime metabolic health and disease."

Abstract
Full Text (subscription or payment may be required)